Peter Kash

Dr. Peter Kash is a co-founder and a lead investor in TargImmune Therapeutics. He is a global biotech entrepreneur and has raised significant capital for private biotech companies. He has co-founded and co-financed more than a dozen biotech companies. Collectively the companies he co-founded have 6 FDA approved drugs.

Dr. Kash was a Adjunct Professor of Entrepreneurship at the Wharton School of Business and has been a Visiting Professor at several other leading universities including Hebrew University in Israel and Nihon University in Japan. He holds a BSc in Management Science, an MBA in Banking and International Finance and a Doctorate in Education. He has authored several books, two of which were international bestsellers.